biorasi Blogs

31. Dermatology Detectives: How The Right Principal Investigator Can Increase Patient Trust And Compliance 5/6/2019

    When conducting complex dermatology clinical trials with difficult to treat, rare, or complicated skin conditions, the study’s success or failure can often hinge on the relationship between the PI and patients. Learn what to look for in a dermatology study investigator.

32. Cosmeceuticals: How To Navigate The Legal And Regulatory Hurdles Of A Growing Market 5/3/2019

    Laws and regulations differ greatly between drugs and cosmetics. Drugs must be submitted for FDA approval. Cosmetics are not. Product manufacturers should know what constitutes a legitimately clinically proven cosmeceutical, as well as what the FDA has to say about these cosmetic-drug hybrids.

33. What Is The Skin Microbiome? 5/3/2019

    The microbiome refers to the genetic material of all the microbes that live on and inside the human body. Using DNA sequencing, researchers are only beginning to uncover links between the microbiome and a host of diseases, including several types of cancer, autoimmune conditions, inflammatory bowel disease, and Crohn’s disease, among others.

34. The Current Standing Of Research On Stem Cell Therapies For Wound Healing 5/2/2019

    Wound healing is a complicated and dynamic process that includes multiple overlapping phases. To control costs and improve outcomes for wound-care patients, researchers are turning to regenerative medicine; specifically, stem cell therapy. Read more about the types of stem cells and how they assist with wound healing.

35. A Deep Dive Into NASH Physiology And Drug Targets 5/1/2019

    One of the problems with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been a lack of understanding of the basic science. Up until the past few years, the treatment approach outside of changing lifestyle factors (i.e. diet and exercise) has been to repurpose old drugs that were used for metabolic syndrome or type 2 diabetes, since these diseases overlap in many ways. By continuing to study the basic science behind the disease and the drugs designed to treat it so that better, more specific drugs may be developed in the future.

36. How Managers Can Establish Good Working Relationships With Their Internal Team 5/1/2019

    A team is only as successful as its leadership, and leading successfully and gracefully is both an art and a science; a title does not make a manager. Following are some of the qualities a strong manager will have.

37. You're Holding Your Eye Drops Wrong – What Makes Ophthalmology Trials So Challenging? 4/30/2019

    Recently, one of our resident experts in ophthalmology, Ignacio Handal, gave a training for some of our current studies with a focus on which pitfalls to avoid specifically in ophthalmology trials. He dished out many fun facts and eye-opening insights.

38. The Politics of Investigator-Initiated Trials 4/30/2019

    IITs present a way for post-marketing, real-world data to be added to a drug or device’s portfolio without the sponsor initiating the research. Everyone can agree on the fact that more research, and especially real world evidence, is helpful for advancing the field of medicine, but not everyone is always in favor of IITs. Following are problems and benefits of IITs.

39. Managing Alzheimer's Trials In A Diverse Global Environment 4/29/2019

    Multinational or not, study sites in a clinical trial must be standardized to follow the same protocol. Disparities and issues with standardization make it difficult to run successful, generalizable Alzheimer’s trials. Read on to learn about common disparities and faced in the Alzheimer trial space along with possible solutions.

40. How Are Adaptive Trial Designs Improving Efficiency In Clinical Research? 4/29/2019

    The ability to adapt is a valued attribute in today’s constantly changing world, and clinical trial designs are no exception. Adaptive trial designs can save sponsors significant time and money, but they need to be approached with caution and planning.